Next report date
Report period
Q1 2024
EPS estimate
−0.32USD
Revenue estimate
—
−48.61 MUSD
204.00 KUSD
40.92 M
About CG Oncology, Inc.
Sector
Industry
CEO
Arthur Kuan
Website
Headquarters
Irvine
Employees (FY)
61
Founded
2010
FIGI
BBG00YHKK4Q3
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CGON is 40.62 USD — it has increased by 1.07% in the past 24 hours. Watch CG Oncology, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CG Oncology, Inc. stocks are traded under the ticker CGON.
CG Oncology, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
CGON stock is 8.01% volatile and has beta coefficient of 3.14. Track CG Oncology, Inc. stock price on the chart and check out the list of the most volatile stocks — is CG Oncology, Inc. there?
Yes, you can track CG Oncology, Inc. financials in yearly and quarterly reports right on TradingView.
CGON stock has risen by 11.93% compared to the previous week, the month change is a 7.30% fall, over the last year CG Oncology, Inc. has showed a 40.07% increase.
CGON net income for the last quarter is −16.12 M USD, while the quarter before that showed −8.39 M USD of net income which accounts for −92.04% change. Track more CG Oncology, Inc. financial stats to get the full picture.
No, CGON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CGON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CG Oncology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CGON reached its all-time high on Feb 16, 2024 with the price of 50.23 USD, and its all-time low was 28.55 USD and was reached on Jan 25, 2024. View more price dynamics on CGON chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 61.00 employees. See our rating of the largest employees — is CG Oncology, Inc. on this list?
We've gathered analysts' opinions on CG Oncology, Inc. future price: according to them, CGON price has a max estimate of 86.00 USD and a min estimate of 43.00 USD. Watch CGON chart and read a more detailed CG Oncology, Inc. stock forecast: see what analysts think of CG Oncology, Inc. and suggest that you do with its stocks.